Shineway Pharmaceutical Financial Statements
Shineway Pharmaceutical Financial Information
| Company Type | Public Single Location |
|---|
© 2009 Morningstar, Inc. Financial Data provided by
Shineway Pharmaceutical Income Statement
| 2008 | 2007 | 2006 | |
|---|---|---|---|
| Revenue ($ mil.) | 186.0 | 138.5 | 107.6 |
| Gross Profit ($ mil.) | 133.4 | 100.9 | 75.8 |
| Operating Income ($ mil.) | -- | -- | -- |
| Total Net Income ($ mil.) | 58.1 | 67.1 | 42.6 |
| Diluted EPS (Net Income) | 0.07 | 0.08 | 0.05 |
Shineway Pharmaceutical Financial Ratios
| Company | Industry Median |
Market Median1 |
|
|---|---|---|---|
| Price/Sales Ratio | 6.40 | 2.58 | 7.01 |
| Price/Earnings Ratio | 20.53 | 16.39 | 25.51 |
| Price/Book Ratio | 3.82 | 2.81 | 6.74 |
| Price/Cash Flow Ratio | 20.12 | 9.89 | 43.48 |
1 Public companies trading on the New York Stock Exchange, the American Stock Exchange, and the NASDAQ National Market.
Detailed Shineway Pharmaceutical Financial Ratios
